Aclaris Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Aclaris Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -26.3 %, a 59.3% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Return On Equity for 2023 was -52.8 %, a 26.6% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Return On Equity for 2022 was -41.7 %, a 12.8% increase from 2021.
  • Aclaris Therapeutics, Inc. annual Return On Equity for 2021 was -47.8 %, a 56.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -52.8 -11.1 -26.6% Jan 1, 2023 Dec 31, 2023
2022 -41.7 +6.11 +12.8% Jan 1, 2022 Dec 31, 2022
2021 -47.8 +61.9 +56.4% Jan 1, 2021 Dec 31, 2021
2020 -110 +26.2 +19.3% Jan 1, 2020 Dec 31, 2020
2019 -136 -63.8 -88.5% Jan 1, 2019 Dec 31, 2019
2018 -72.1 -37.8 -110% Jan 1, 2018 Dec 31, 2018
2017 -34.4 +11 +24.3% Jan 1, 2017 Dec 31, 2017
2016 -45.4 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.